1. Home
  2. FPS vs BBIO Comparison

FPS vs BBIO Comparison

Compare FPS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forgent Power Solutions Inc. Class A Common Stock

FPS

Forgent Power Solutions Inc. Class A Common Stock

N/A

Current Price

$45.59

Market Cap

14.3B

Sector

Energy

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$86.01

Market Cap

12.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPS
BBIO
Founded
2023
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3B
12.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FPS
BBIO
Price
$45.59
$86.01
Analyst Decision
Buy
Strong Buy
Analyst Count
8
25
Target Price
$42.63
$86.33
AVG Volume (30 Days)
7.5M
3.6M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$74.33
$89.45
Revenue Next Year
$43.11
$73.78
P/E Ratio
$526.99
N/A
Revenue Growth
N/A
126.26
52 Week Low
$27.27
$42.09
52 Week High
$66.00
$93.42

Technical Indicators

Market Signals
Indicator
FPS
BBIO
Relative Strength Index (RSI) 37.83 73.76
Support Level $28.96 $62.93
Resistance Level $51.00 N/A
Average True Range (ATR) 3.85 3.18
MACD -1.82 1.77
Stochastic Oscillator 10.75 72.69

Price Performance

Historical Comparison
FPS
BBIO

About FPS Forgent Power Solutions Inc. Class A Common Stock

Forgent Power Solutions Inc designs and manufactures electrical distribution equipment for data centers, the power grid, and industrial facilities. Its offerings include automatic transfer switches, transformers (dry type and liquid filled), electrical houses, generator connection cabinets, panelboards, switchboards, switchgear, power distribution units, power skids, remote power panels, and tap boxes.It specializes in manufacturing Custom Products and Powertrain Solutions for technically demanding applications, including data center power distribution, utility substations and energy-intensive manufacturing. The majority of the company's revenue is derived from custom products designed for specific projects with significant engineering consultation.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: